main content start
About Us
ADA Newsroom
Get the latest news from ADA, including press releases and research announcements.
Press Releases
If you are looking for ADA press releases issued prior to 2019, please email press@diabetes.org.
Recent Press release
Press release
One in Four Patients with Difficult-to-Control Type 2 Diabetes Experience High Levels of Cortisol
Largest-Study-of-its-Kind Uncovers Potential Underlying
Press release
Common Type 2 Diabetes Drug Shown to Safely Reduce the Progression of Kidney Disease in Adolescents with Type 1 Diabetes
SGLT2i Shown as Potential Solution to Help Manage Renal
Press release
Semaglutide Reduced Risk for Major Kidney Disease Events by 24% for Patients with Type 2 Diabetes and Kidney Disease
American Diabetes Association Symposium Showcases New
Official Statement
Recent Press release
Press release
One in Four Patients with Difficult-to-Control Type 2 Diabetes Experience High Levels of Cortisol
Largest-Study-of-its-Kind Uncovers Potential Underlying
Press release
Common Type 2 Diabetes Drug Shown to Safely Reduce the Progression of Kidney Disease in Adolescents with Type 1 Diabetes
SGLT2i Shown as Potential Solution to Help Manage Renal
Press release
Semaglutide Reduced Risk for Major Kidney Disease Events by 24% for Patients with Type 2 Diabetes and Kidney Disease
American Diabetes Association Symposium Showcases New
Press release
Expanded FORWARD Trial Demonstrates Continued Potential for Stem Cell-Derived Islet Cell Therapy to Eliminate Need for Insulin for People with T1D
American Diabetes Association Symposium Shows Patients with Type 1 Diabetes Experienced Insulin Independence and Elimination of Severe
Press release
Use of Tirzepatide Shown to Improve Sleep Apnea and Cardiovascular Outcomes
SURMOUNT-OSA Study Highlights Potential Dual-Action Benefits of Novel Therapy for Obesity Today, findings from the SURMOUNT-OSA, a study…
Press release
Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients
First-of-Its-Kind Study Shows Fenofibrate Reduces Eye Disease Progression by 27% Today, findings from the Lowering Events in Non
Meet Our Experts
The American Diabetes Association is proud to partner with leading experts in the field of diabetes—each one directed to advancing the treatment and prevention of this disease.
Charles D. Henderson
Chief Executive Officer
Robert Gabbay, MD, PhD
Chief Scientific and Medical Officer
Lisa Murdock
Chief Advocacy Officer
Nuha El Sayed, MD, MMSc
Senior Vice President, Health Care Improvement
Marlon Pragnell, PhD
Vice President, Research & Science
Crystal Woodward, MPS
Managing Director, Legal Advocacy/Safe at School
Your support helps drive lifesaving research, advocacy, and programs to help improve the lives of people living with diabetes.
Donate Now and DOUBLE your impact.